675 / 1138
Overview of talk
•
Multi-disciplinary tumor board (ESMO guidelines)
•
SABR guidelines (technical)
•
Patient selection (operable, pathology, PET –ve cases)
•
Toxicity and local control (peripheral tumors)
•
Controversies: central tumors, tumors <1 cm
•
Follow up: Recurrence or fibrosis
•
Second Primary Lung Cancer (SPLC)